98%
921
2 minutes
20
Mesenchymal chondrosarcoma (MC) is an extremely rare subtype of chondrosarcoma. A tumor specific fusion gene, HEY1-NCOA2 fusion, was recently identified in this tumor. The finding raises the possibility that the diagnosis of MC can be improved by examining the fusion gene. In the present study, we aimed to evaluate the efficacy of fluorescence in situ hybridization (FISH) in detecting HEY1-NCOA2 fusion for the diagnosis of MC. Specimens from 10 patients diagnosed with MC were used for the study. Dual-color FISH was performed using two different probes that specifically hybridize to HEY1 and NCOA2, respectively. Fusion signals were identified in all but two specimens, in which no signal was detected, presumably because of inadequate sample preparation. In accordance with results of a previous study, FISH analysis was highly sensitive in detecting HEY1-NCOA2 fusion in adequately prepared MC samples. The current study adds further support for the use of HEY1-NCOA2 fusion as a valid diagnostic marker for MC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/pin.12022 | DOI Listing |
Cureus
July 2025
Department of Neurosurgery, St. Marianna Medical University, Kawasaki, JPN.
We report a rare case of a dumbbell-shaped mesenchymal chondrosarcoma (MCS) in the lumbar canal. A 29-year-old man presented with lower back pain and pain in the left leg. Magnetic resonance imaging (MRI) showed a homogeneously enhanced dumbbell-shaped mass at the left L2-3 level.
View Article and Find Full Text PDFOral Oncol
August 2025
Department of Oral Pathology and Microbiology, Center for Dental Education and Research, All India Institute of Medical Sciences, New Delhi, India. Electronic address:
Mesenchymal chondrosarcoma (MC) is a rare, aggressive malignancy characterized by a distinctive biphasic histological pattern and frequently associated with the HEY1::NCOA2 fusion gene. We report a case of a 17-year-old male presenting with a mandibular mass initially suspected to be a benign chondro-osseous lesion. Following segmental mandibulectomy, histopathological examination revealed classical features of MC, including undifferentiated small round to spindle cells arranged around staghorn vasculature and islands of mature hyaline cartilage.
View Article and Find Full Text PDFBMC Ophthalmol
April 2025
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China.
Background: Mesenchymal chondrosarcoma (MC) is an uncommon type of malignant soft tissue tumor. The skeleton is the most common site of MC. Extraosseous sarcoma is rare, especially that of the orbit.
View Article and Find Full Text PDFJCO Precis Oncol
March 2025
Medical Oncology, University of Washington, Seattle, WA.
Purpose: Chondrosarcomas are rare cancers of cartilage with limited systemic therapy options. To identify potential therapeutic targets, this study investigated the molecular and immune landscape of three chondrosarcoma subtypes using a large database of clinical-grade sequencing results.
Methods: Deidentified records from patients with a histologic diagnosis of conventional, dedifferentiated, or mesenchymal chondrosarcoma sequenced by the Tempus xT DNA assay were included.
Pathol Oncol Res
August 2024
Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Introduction: Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS) is one of the most common origins of extraosseous MCS. However, alternative fusions have not been reported in this tumor.
View Article and Find Full Text PDF